{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:11:10Z","timestamp":1778652670755,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Interdisciplinary Program of Shanghai Jiao Tong University","award":["YG2022ZD017)"],"award-info":[{"award-number":["YG2022ZD017)"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372388"],"award-info":[{"award-number":["82372388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03978-8","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:03:35Z","timestamp":1772867015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluoroalkylated antimicrobial peptides enables cytosolic delivery and eradication of intracellular Staphylococcus aureus"],"prefix":"10.1186","volume":"24","author":[{"given":"Tao","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbo","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"3978_CR1","doi-asserted-by":"publisher","first-page":"2109789","DOI":"10.1002\/adma.202109789","volume":"34","author":"WL Feng","year":"2022","unstructured":"Feng WL, Li GF, Kang XX, Wang RB, Liu F, Zhao DD, et al. Cascade-targeting poly(amino acid) nanoparticles eliminate intracellular bacteria via on-site antibiotic delivery. Adv Mater. 2022;34:2109789. https:\/\/doi.org\/10.1002\/adma.202109789","journal-title":"Adv Mater"},{"key":"3978_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.aambs.2020.05.001","volume":"112","author":"KE Watkins","year":"2020","unstructured":"Watkins KE, Unnikrishnan M. Evasion of host defenses by intracellular Staphylococcus aureus. Adv Appl Microbiol. 2020;112:105\u201341.","journal-title":"Adv Appl Microbiol"},{"issue":"12","key":"3978_CR3","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.3390\/ijms25126486","volume":"25","author":"CF Volk","year":"2024","unstructured":"Volk CF, Proctor RA, Rose WE. The complex intracellular lifecycle of Staphylococcus aureus contributes to reduced antibiotic efficacy and persistent bacteremia. Int J Mol Sci. 2024;25(12):6486. https:\/\/doi.org\/10.3390\/ijms25126486","journal-title":"Int J Mol Sci"},{"key":"3978_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.134057","volume":"469","author":"X Ma","year":"2024","unstructured":"Ma X, Kaw HY, Yu J, Yang Q, Zhu L, Wang W. The intracellular concentrations of fluoroquinolones determined the antibiotic resistance response of Escherichia coli. J Hazard Mater. 2024;469:134057.","journal-title":"J Hazard Mater"},{"issue":"10325","key":"3978_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Global burden of bacterial antimicrobial resistance","year":"2022","unstructured":"Global burden of bacterial antimicrobial resistance. In 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"issue":"10369","key":"3978_CR6","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"Global mortality associated","year":"2022","unstructured":"Global mortality associated. With 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10369):2221\u201348.","journal-title":"Lancet"},{"issue":"10459","key":"3978_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"Global burden of bacterial antimicrobial","year":"2024","unstructured":"Global burden of bacterial antimicrobial. Resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"issue":"10459","key":"3978_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"Collaborators GBDAR","year":"2024","unstructured":"Collaborators GBDAR. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"key":"3978_CR9","doi-asserted-by":"crossref","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603\u201361.","DOI":"10.1128\/CMR.00134-14"},{"issue":"1","key":"3978_CR10","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/s41467-020-15966-7","volume":"11","author":"F Peyrusson","year":"2020","unstructured":"Peyrusson F, Varet H, Nguyen TK, Legendre R, Sismeiro O, Copp\u00e9e JY, et al. Intracellular Staphylococcus aureus persisters upon antibiotic exposure. Nat Commun. 2020;11(1):2200.","journal-title":"Nat Commun"},{"issue":"5","key":"3978_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202201409","volume":"7","author":"S Jia","year":"2023","unstructured":"Jia S, Ji S, Zhao J, Lv Y, Wang J, Sun D, et al. A fluorinated supramolecular self-assembled peptide as nanovaccine adjuvant for enhanced cancer vaccine therapy. Small Methods. 2023;7(5):e2201409.","journal-title":"Small Methods"},{"issue":"2","key":"3978_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1302\/2046-3758.92.BJR-2019-0201.R1","volume":"9","author":"T Gao","year":"2020","unstructured":"Gao T, Lin J, Zhang C, Zhu H, Zheng X. Is intracellular Staphylococcus aureus associated with recurrent infection in a rat model of open fracture? Bone Joint Res. 2020;9(2):71\u20136.","journal-title":"Bone Joint Res"},{"issue":"5","key":"3978_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","volume":"19","author":"N Mookherjee","year":"2020","unstructured":"Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ. Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov. 2020;19(5):311\u201332.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"3978_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41579-023-00993-0","volume":"22","author":"CR MacNair","year":"2024","unstructured":"MacNair CR, Rutherford ST, Tan MW. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat Rev Microbiol. 2024;22(5):262\u201375.","journal-title":"Nat Rev Microbiol"},{"key":"3978_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100954","volume":"68","author":"J Xuan","year":"2023","unstructured":"Xuan J, Feng W, Wang J, Wang R, Zhang B, Bo L, et al. Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resistance Updates. 2023;68:100954.","journal-title":"Drug Resistance Updates"},{"key":"3978_CR16","doi-asserted-by":"crossref","unstructured":"Wang G, Schmidt C, Li X, Wang Z. APD6: the antimicrobial peptide database is expanded to promote research and development by deploying an unprecedented information pipeline. Nucleic Acids Res. 2025, gkaf860.","DOI":"10.1093\/nar\/gkaf860"},{"issue":"4","key":"3978_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/1751-7915.14213","volume":"16","author":"MG Ciulla","year":"2023","unstructured":"Ciulla MG, Gelain F. Structure-activity relationships of antibacterial peptides. Microb Biotechnol. 2023;16(4):757\u201377.","journal-title":"Microb Biotechnol"},{"key":"3978_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101289","volume":"83","author":"N Gao","year":"2025","unstructured":"Gao N, Sun J, Li X, Yao Y, Hu Y, Zhao J, et al. Overcoming delivery challenges of antimicrobial peptides for clinical translation: from nanocarriers to molecular modifications. Drug Resist Updat. 2025;83:101289.","journal-title":"Drug Resist Updat"},{"issue":"10","key":"3978_CR19","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1021\/acs.accounts.1c00040","volume":"54","author":"ME Schafer","year":"2021","unstructured":"Schafer ME, Browne H, Goldberg JB, Greenberg DE. Peptides and antibiotic therapy: advances in design and delivery. Acc Chem Res. 2021;54(10):2377\u201385.","journal-title":"Acc Chem Res"},{"issue":"6","key":"3978_CR20","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1021\/acsnano.5b00491","volume":"9","author":"BC Evans","year":"2015","unstructured":"Evans BC, Hocking KM, Kilchrist KV, Wise ES, Brophy CM, Duvall CL. Endosomolytic nano-polyplex platform technology for cytosolic peptide delivery to inhibit pathological vasoconstriction. ACS Nano. 2015;9(6):5893\u2013907.","journal-title":"ACS Nano"},{"issue":"3","key":"3978_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jconrel.2012.01.039","volume":"158","author":"JL Zaro","year":"2012","unstructured":"Zaro JL, Fei L, Shen WC. Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery. J Control Release. 2012;158(3):357\u201361.","journal-title":"J Control Release"},{"issue":"23","key":"3978_CR22","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1021\/jacs.7b01698","volume":"139","author":"L Peraro","year":"2017","unstructured":"Peraro L, Zou Z, Makwana KM, Cummings AE, Ball HL, Yu H, et al. Diversity-oriented stapling yields intrinsically cell-penetrant inducers of autophagy. J Am Chem Soc. 2017;139(23):7792\u2013802.","journal-title":"J Am Chem Soc"},{"issue":"17","key":"3978_CR23","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1002\/anie.201801167","volume":"57","author":"JM Wolfe","year":"2018","unstructured":"Wolfe JM, Fadzen CM, Holden RL, Yao M, Hanson GJ, Pentelute BL. Perfluoroaryl bicyclic cell-penetrating peptides for delivery of antisense oligonucleotides. Angew Chem Int Ed Engl. 2018;57(17):4756\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3978_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cbpa.2020.01.004","volume":"55","author":"L Wu","year":"2020","unstructured":"Wu L, Maglangit F, Deng H. Fluorine biocatalysis. Curr Opin Chem Biol. 2020;55:119\u201326.","journal-title":"Curr Opin Chem Biol"},{"issue":"9","key":"3978_CR25","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41557-022-00996-z","volume":"14","author":"A Rittner","year":"2022","unstructured":"Rittner A, Joppe M, Schmidt JJ, Mayer LM, Reiners S, Heid E, et al. Chemoenzymatic synthesis of fluorinated polyketides. Nat Chem. 2022;14(9):1000\u20136.","journal-title":"Nat Chem"},{"issue":"5","key":"3978_CR26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1021\/acs.accounts.1c00766","volume":"55","author":"J Lv","year":"2022","unstructured":"Lv J, Wang H, Rong G, Cheng Y. Fluorination promotes the cytosolic delivery of genes, proteins, and peptides. Acc Chem Res. 2022;55(5):722\u201333.","journal-title":"Acc Chem Res"},{"issue":"1","key":"3978_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1021\/acs.chemrev.1c00632","volume":"122","author":"C Zhang","year":"2022","unstructured":"Zhang C, Yan K, Fu C, Peng H, Hawker CJ, Whittaker AK. Biological utility of fluorinated compounds: from materials design to molecular imaging, therapeutics and environmental remediation. Chem Rev. 2022;122(1):167\u2013208.","journal-title":"Chem Rev"},{"issue":"19","key":"3978_CR28","doi-asserted-by":"publisher","first-page":"10633","DOI":"10.1021\/acsomega.0c00830","volume":"5","author":"M Inoue","year":"2020","unstructured":"Inoue M, Sumii Y, Shibata N. Contribution of organofluorine compounds to pharmaceuticals. ACS Omega. 2020;5(19):10633\u201340.","journal-title":"ACS Omega"},{"issue":"25","key":"3978_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202500662","volume":"31","author":"Y Du","year":"2025","unstructured":"Du Y, Bian Y, Baecker D, Dhawan G, Semghouli A, Kiss L, et al. Fluorine in the Pharmaceutical Industry: FDA-Approved Fluorine-Containing Drugs in 2024. Chemistry. 2025;31(25):e202500662.","journal-title":"Chemistry"},{"issue":"9","key":"3978_CR30","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1039\/D0CS00258E","volume":"50","author":"J Lv","year":"2021","unstructured":"Lv J, Cheng Y. Fluoropolymers in biomedical applications: state-of-the-art and future perspectives. Chem Soc Rev. 2021;50(9):5435\u201367.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"3978_CR31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1021\/acsnano.1c09456","volume":"16","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang J, Tu Y, Zhu L. Potential-independent intracellular drug delivery and mitochondrial targeting. ACS Nano. 2022;16(1):1409\u201320.","journal-title":"ACS Nano"},{"issue":"30","key":"3978_CR32","doi-asserted-by":"publisher","first-page":"e2404645","DOI":"10.1002\/adma.202404645","volume":"36","author":"J Xin","year":"2024","unstructured":"Xin J, Lu X, Cao J, Wu W, Liu Q, Wang D, et al. Fluorinated organic polymers for cancer drug delivery. Adv Mater. 2024;36(30):e2404645. https:\/\/doi.org\/10.1002\/adma.202404645","journal-title":"Adv Mater"},{"key":"3978_CR33","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1038\/ncomms4053","volume":"5","author":"M Wang","year":"2014","unstructured":"Wang M, Liu H, Li L, Cheng Y. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios. Nat Commun. 2014;5:3053.","journal-title":"Nat Commun"},{"issue":"5","key":"3978_CR34","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1021\/acsami.6b14184","volume":"9","author":"G Chen","year":"2017","unstructured":"Chen G, Wang K, Hu Q, Ding L, Yu F, Zhou Z, et al. Combining fluorination and bioreducibility for improved SiRNA polyplex delivery. ACS Appl Mater Interfaces. 2017;9(5):4457\u201366.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3978_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jconrel.2023.10.001","volume":"363","author":"Y Deng","year":"2023","unstructured":"Deng Y, Zhang J, Sun X, Li L, Zhou M, Liu S, et al. Potent gene delivery from fluorinated poly(\u03b2-amino ester) in adhesive and suspension difficult-to-transfect cells for apoptosis and ferroptosis. J Control Release. 2023;363:597\u2013605.","journal-title":"J Control Release"},{"issue":"10","key":"3978_CR36","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1021\/ar500125m","volume":"47","author":"EN Marsh","year":"2014","unstructured":"Marsh EN. Fluorinated proteins: from design and synthesis to structure and stability. Acc Chem Res. 2014;47(10):2878\u201386.","journal-title":"Acc Chem Res"},{"issue":"28","key":"3978_CR37","doi-asserted-by":"publisher","first-page":"10176","DOI":"10.1039\/D2NR01648F","volume":"14","author":"S Chowdhary","year":"2022","unstructured":"Chowdhary S, Schmidt RF, Sahoo AK, Tom Dieck T, Hohmann T, Schade B, et al. Rational design of amphiphilic fluorinated peptides: evaluation of self-assembly properties and hydrogel formation. Nanoscale. 2022;14(28):10176\u201389.","journal-title":"Nanoscale"},{"issue":"33","key":"3978_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz1774","volume":"6","author":"G Rong","year":"2020","unstructured":"Rong G, Wang C, Chen L, Yan Y, Cheng Y. Fluoroalkylation promotes cytosolic peptide delivery. Sci Adv. 2020;6(33):eaaz1774.","journal-title":"Sci Adv"},{"issue":"10","key":"3978_CR39","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41587-019-0222-z","volume":"37","author":"R Mourtada","year":"2019","unstructured":"Mourtada R, Herce HD, Yin DJ, Moroco JA, Wales TE, Engen JR, et al. Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice. Nat Biotechnol. 2019;37(10):1186\u201397.","journal-title":"Nat Biotechnol"},{"key":"3978_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jconrel.2023.03.051","volume":"357","author":"H Li","year":"2023","unstructured":"Li H, Bruce G, Childerhouse N, Keegan G, Mantovani G, Stolnik S. Biotin receptor-mediated intracellular delivery of synthetic polypeptide-protein complexes. J Control Release. 2023;357:333\u201341.","journal-title":"J Control Release"},{"issue":"11","key":"3978_CR42","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1021\/acsbiomaterials.4c01544","volume":"10","author":"S Wang","year":"2024","unstructured":"Wang S, Ong ZY, Qu S, Wang Y, Xin J, Zheng Z, et al. Omiganan-based synthetic antimicrobial peptides for the healthcare of infectious endophthalmitis. ACS Biomater Sci Eng. 2024;10(11):7217\u201326. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c01544","journal-title":"ACS Biomater Sci Eng"},{"key":"3978_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122045","volume":"624","author":"A Javia","year":"2022","unstructured":"Javia A, Misra A, Thakkar H. Liposomes encapsulating novel antimicrobial peptide Omiganan: characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model. Int J Pharm. 2022;624:122045.","journal-title":"Int J Pharm"}],"updated-by":[{"DOI":"10.1186\/s12951-026-04517-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000}}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03978-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:37:59Z","timestamp":1778650679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03978-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03978-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12951-026-04517-9","URL":"https:\/\/doi.org\/10.1186\/s12951-026-04517-9","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed in accordance with protocols approved by the Ethics Committee of Shanghai Chengxi Biotechnology Co., Ltd (Approval No. CX052403087).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}